Hydrabad, India — CFKR STC Couriers, a logistics provider focused exclusively on pharmaceutical and life science supply chains, today announced an expansion of its cold chain packaging and pharmaceutical cold storage capabilities across its Indian network. The move responds to growing demand from manufacturers, clinical research organizations, and biotech firms for a logistics partner that can guarantee temperature integrity from the point of manufacture through to final delivery.
With more than three decades of experience in temperature-controlled transport, STC Couriers has built its business around a single principle: pharmaceutical shipments cannot be treated as ordinary freight. Vaccines, biologics, insulin, and increasingly cell and gene therapies require packaging systems that are engineered, tested, and qualified for the exact route and duration they will travel, not generic insulated boxes applied across every shipment type.
"Every shipment we handle represents a product that took years to develop and months to manufacture," said a spokesperson for CFKR STC Couriers. "A single temperature excursion can undo all of that in a matter of hours. Our expansion is about making sure that risk never becomes a reality for the manufacturers who trust us with their products."
The expanded network includes additional temperature-mapped storage facilities, a wider fleet of validated refrigerated vehicles, and deeper integration with air cargo partners certified under global pharmaceutical handling standards. The company has also strengthened its documentation systems, giving clients real-time visibility into temperature logs and chain of custody records throughout transit, a requirement that has become non-negotiable for manufacturers operating under Good Distribution Practice guidelines.
Pharmaceutical cold storage in India has come under increasing scrutiny as the country's export volumes have grown, and manufacturers shipping into regulated markets abroad face compliance expectations that a general logistics provider is rarely equipped to meet. STC Couriers has positioned itself to close that gap by offering packaging technology, warehousing, and last-mile delivery under a single accountable service, rather than a chain of vendors handing off responsibility at each stage.
The company's capabilities now span cold chain transportation, clinical trial logistics, cell and gene supply chain handling, and regulatory compliance support, all built around the same core commitment to validated, auditable temperature control. This expansion follows a period of steady growth in the company's client base among pharmaceutical manufacturers, biotech firms, and clinical research organizations seeking a specialized partner over a general 3PL.
"We are not trying to be a logistics company that also does pharma," the spokesperson added. "Pharma is the only thing we do, and that focus is what allows us to catch problems before they become deviations."
CFKR STC Couriers continues to invest in its packaging technology and monitoring systems as part of a broader plan to support the next generation of temperature-sensitive therapies, including cryogenic and ultra-cold shipments that demand even tighter tolerances than traditional vaccine cold chains.
About CFKR STC Couriers
CFKR STC Couriers is a logistics company dedicated to pharmaceutical and life science supply chains, offering cold chain transportation, validated packaging technology, clinical trial logistics, and regulatory compliance support. With more than 30 years of experience, the company serves pharmaceutical manufacturers and healthcare organizations with secure, temperature-controlled delivery across air, ocean, and ground freight. More information is available at stccouriers.in.
Media Contact
CFKR STC Couriers
Website: https://stccouriers.in/
Contact: https://stccouriers.in/reach-out-to-cfkr-stc-couriers/